Welch Materials, Inc. – Trademark Portfolio
Entity Type: 03
Welch Materials, Inc. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 4 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include ULTISIL, XTIMATE, BOLTIMATE, and WELPROTECTOR. The owner is based in Songjiang Qu, Shanghai.
Building 10, Zijing Park
Tus-Caohejing Sci. Park, 85 Mingnan RD.
Songjiang Qu, Shanghai 201600 , CN
Showing of trademarks Trademarks
Trademark Classifications
Welch Materials, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Welch Materials, Inc. have?
Welch Materials, Inc. has 5 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 abandoned.
What trademark classes does Welch Materials, Inc. file in?
Welch Materials, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 5 (Pharmaceuticals). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Welch Materials, Inc.'s most well-known trademarks?
Welch Materials, Inc.'s registered trademark portfolio includes well-known marks such as ULTISIL, XTIMATE, BOLTIMATE, and WELPROTECTOR. These are among 4 currently registered trademarks in the portfolio.
What is Welch Materials, Inc.'s trademark registration success rate?
Welch Materials, Inc. has a 80% trademark registration rate, with 4 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.